Growth Metrics

Insulet (PODD) Cash & Equivalents Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.15%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 24.05%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -7.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -22.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 23.57%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -7.71%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 156.03%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn -62.56%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -62.56%
Dec 31, 2025 -24.89%
Sep 30, 2025 -16.09%
Jun 30, 2025 36.61%
Mar 31, 2025 70.81%
Dec 31, 2024 35.39%
Sep 30, 2024 31.69%
Jun 30, 2024 24.38%
Mar 31, 2024 21.02%
Dec 31, 2023 4.37%
Sep 30, 2023 -5.07%
Jun 30, 2023 -6.84%
Mar 31, 2023 -12.53%
Dec 31, 2022 -14.77%
Sep 30, 2022 -15.71%
Jun 30, 2022 -17.08%
Mar 31, 2022 -13.54%
Dec 31, 2021 -12.74%
Sep 30, 2021 2.21%
Jun 30, 2021 9.69%
Mar 31, 2021 307.50%
Dec 31, 2020 324.52%
Sep 30, 2020 99.60%
Jun 30, 2020 549.97%
Mar 31, 2020 55.82%
Dec 31, 2019 87.62%
Sep 30, 2019 231.76%
Jun 30, 2019 -12.02%
Mar 31, 2019 -36.37%
Dec 31, 2018 -58.21%
Sep 30, 2018 23.80%
Jun 30, 2018 85.40%
Mar 31, 2018 167.16%
Dec 31, 2017 98.71%
Sep 30, 2017 -52.54%
Jun 30, 2017 -2.87%
Mar 31, 2017 -31.89%
Dec 31, 2016 11.82%
Sep 30, 2016 48.08%
Jun 30, 2016 -47.87%
Mar 31, 2016 -23.33%
Dec 31, 2015 -18.86%
Sep 30, 2015 -0.62%
Jun 30, 2015 -17.32%
Mar 31, 2015 -0.52%
Dec 31, 2014 0.98%
Sep 30, 2014 -4.89%
Jun 30, 2014 16.30%
Mar 31, 2014 -1.14%
Dec 31, 2013 161.34%
Sep 30, 2013 142.59%
Jun 30, 2013 115.19%
Mar 31, 2013 78.38%
Dec 31, 2012 -39.02%
Sep 30, 2012 -38.89%
Jun 30, 2012 -34.29%
Mar 31, 2012 -20.56%
Dec 31, 2011 -17.06%
Sep 30, 2011 -0.10%
Jun 30, 2011 -9.59%